Author:
Goffinet F.,Anselem O.,Barrois M.,Girault A.,Grangé G.,Lepercq J.,Le Ray C.,Pannier E.,Theau A.,Tsatsaris V.
Reference8 articles.
1. ACOG Committee Opinion No. 767 Summary: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period. Obstet Gynecol. 2019 Feb;133(2):409-12.
2. Atallah A, Lecarpentier E, Goffinet F, Gaucherand P, Doret-Dion M, Tsatsaris V. Aspirin and Preeclampsia. Presse Med. 2019 Jan;48(1 Pt 1):34-45. doi: 10.1016/j.lpm. 2018.11.022. Epub 2019 Jan 18.
3. CNGOF et SFAR Guidelines for the management of women with severe preeclampsia: http://www.cngof.fr/pratiques-cliniques/recommandations-pour-la-pratique- clinique/apercu?path=RPC %2BCOLLEGE %252F2021 %252FRFE %2Bpre-eclampsie_2020.pdf&i=46509
4. Alavifard S, Chase R, Janoudi G, Chaumont A, Lanes A, Walker M, et al. First-line antihypertensive treatment for severe hypertension in pregnancy:bA systematic review and network meta-analysis. Pregnancy Hypertens 2019 Oct;18:179-87.
5. Benefits and risks of expectant management of severe preeclampsia at less than 26 weeks gestation: the impact of gestational age and severe fetal growth restriction;Belghiti;Am J Obstet Gynecol,2011